#entresto
Related Stories (2)
Novartis defeats UK court bid to invalidate blockbuster drug Entresto patent - Reuters
Novartis defeats UK court bid to invalidate blockbuster drug Entresto patent Reuters
August 13, 2026Novartis misses quarterly sales, profit estimates as Entresto generics hit growth - Reuters
Novartis misses quarterly sales, profit estimates as Entresto generics hit growth Reuters
April 28, 2026Related Pages (6)
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Novartis shares fall after weak Q1 hit by Entresto competition
AI Sentiment: 18/100 Bearish This score is generated through AI-driven analysis of the article's content. powered by Buy NVS. The stock is down on a predictable, already-announced Entresto patent
Novartis Q1 profit down on US generic erosion
Swiss drugmaker Novartis reported first-quarter core operating profit below market expectations on Tuesday, as generic competition for its top-selling heart drug Entresto weighed on sales. Quarterly
Novartis misses Q1 profit estimates on steep generic erosion
Group operating income is down by 12% at US$4.9 billion, below analyst expectations of US$5.1 billion Share [BASEL] Swiss drugmaker Novartis reported first-quarter core operating profit below market
Novartis misses quarterly sales, profit estimates as Entresto generics hit growth
Take advantage of our newsletter subscription and stay informed on the go!
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa